12 Sep - 26 Sep 2022Rights issue

Pharmiva is a Swedish femtech company that works for better vaginal health by developing innovative antibiotic-free treatments against vaginal infections.

The company’s first product is Vernivia®, a non-prescription CE-certified vaginal mousse with the indication bacterial vaginosis (BV), a common vaginal infection that affects 1 in 3 women aged 14-49. With Vernivia® vaginal mousse, women get access to an effective treatment that both cures the infection and provides rapid symptom relief without at the same time causing the problematic side effects that today’s antibiotic treatments mean for both the individual and global health with the serious development of antibiotic resistance. The launch of Vernivia®, which is sold via pharmacy chains in Sweden, is the first step towards Pharmiva’s goal of becoming a global femtech company with a broad portfolio of antibiotic-free products in vaginal health. Pharmiva’s employees together have broad Life Science experience and knowledge in the field of therapy and product development.

Read more at the company's website

The offer in summary